secwatch.observer — SEC 8-K summary
======================================

Issuer:     Emergent BioSolutions Inc. (EBS)
CIK:        0001367644
Form:       8-K
Filed at:   2024-10-02T23:59:59+00:00
Accession:  0001193125-24-230710
Event type: debt
Sentiment:  positive
Materiality: 0.60
Item codes: 1.01, 2.02, 2.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Emergent BioSolutions closes $100M ABL credit facility, reports $150M cash balance
--------------------------------------------------------------------------------

- New asset-based revolving loan facility of up to $100M, maturing September 2029.
- Cash balance of approximately $150M as of September 30, 2024.
- ABL facility undrawn at closing; provides additional liquidity for transformation plan.
- Facility follows prior $250M term loan refinancing with Oak Hill Advisors in September 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1367644/000119312524230710/0001193125-24-230710-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1367644/000119312524230710/d825659d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-230710

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer